GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Cyclically Adjusted PB Ratio

Medeon Biodesign (ROCO:6499) Cyclically Adjusted PB Ratio : 1.55 (As of Sep. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Cyclically Adjusted PB Ratio?

As of today (2024-09-22), Medeon Biodesign's current share price is NT$44.30. Medeon Biodesign's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was NT$28.54. Medeon Biodesign's Cyclically Adjusted PB Ratio for today is 1.55.

The historical rank and industry rank for Medeon Biodesign's Cyclically Adjusted PB Ratio or its related term are showing as below:

ROCO:6499' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.4   Med: 1.6   Max: 1.8
Current: 1.55

During the past years, Medeon Biodesign's highest Cyclically Adjusted PB Ratio was 1.80. The lowest was 1.40. And the median was 1.60.

ROCO:6499's Cyclically Adjusted PB Ratio is ranked better than
59.34% of 455 companies
in the Medical Devices & Instruments industry
Industry Median: 2.09 vs ROCO:6499: 1.55

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medeon Biodesign's adjusted book value per share data for the three months ended in Jun. 2024 was NT$20.897. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$28.54 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medeon Biodesign Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Medeon Biodesign's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Cyclically Adjusted PB Ratio Chart

Medeon Biodesign Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medeon Biodesign Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.82 1.51 1.79

Competitive Comparison of Medeon Biodesign's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeon Biodesign's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Cyclically Adjusted PB Ratio falls into.



Medeon Biodesign Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medeon Biodesign's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=44.30/28.54
=1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeon Biodesign's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Medeon Biodesign's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=20.897/132.5538*132.5538
=20.897

Current CPI (Jun. 2024) = 132.5538.

Medeon Biodesign Quarterly Data

Book Value per Share CPI Adj_Book
201312 21.964 98.326 29.610
201406 5.834 100.560 7.690
201412 5.122 99.070 6.853
201503 0.000 99.621 0.000
201506 14.311 100.684 18.841
201509 0.000 100.392 0.000
201512 12.879 99.792 17.107
201603 12.176 100.470 16.064
201606 11.532 101.688 15.032
201609 21.307 101.861 27.727
201612 20.323 101.863 26.446
201703 19.544 102.862 25.185
201706 18.782 103.349 24.089
201709 17.969 104.136 22.873
201712 16.929 104.011 21.575
201803 21.582 105.290 27.171
201806 21.355 106.317 26.625
201809 20.736 106.507 25.807
201812 20.623 105.998 25.790
201903 24.445 107.251 30.212
201906 23.089 108.070 28.320
201909 22.280 108.329 27.262
201912 21.747 108.420 26.588
202003 21.180 108.902 25.780
202006 20.447 108.767 24.919
202009 19.398 109.815 23.415
202012 22.319 109.897 26.920
202103 22.269 111.754 26.414
202106 48.810 114.631 56.441
202109 46.120 115.734 52.823
202112 44.886 117.630 50.581
202203 45.109 121.301 49.294
202206 42.249 125.017 44.796
202209 41.202 125.227 43.613
202212 39.095 125.222 41.384
202303 36.848 127.348 38.354
202306 29.532 128.729 30.410
202309 27.616 129.860 28.189
202403 23.155 131.776 23.292
202406 20.897 132.554 20.897

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medeon Biodesign  (ROCO:6499) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medeon Biodesign Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeon Biodesign Business Description

Traded in Other Exchanges
N/A
Address
No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign Headlines

No Headlines